Citations

Showing 10 of 108104 citations.

Standard Operating Procedures for Biospecimen Collection, Processing, and Storage
Fisher, William E., Cruz‐Monserrate, Zobeida , McElhany, Amy L., Hart, Phil A. , Ghosh, Ria , Buren, George Van , Fishman, Douglas S., Rinaudo, Jo Ann, Serrano, José , Srivastava, Sudhir , Mace, Thomas A. , Topazian, Mark , Feng, Ziding , Yadav, Dhiraj , Hughes, Steven J. , Liu, Robert Y., Lu, Emily Y., Orr, Robert Scott, Abouhamze, Amer, Troendle, David M. , Uç, Aliye , Lowe, Mark E. , Conwell, Darwin L. , Whitcomb, David C. , Serrano, Jose , Lesinski, Gregory B , Ghosh, Ria, Pandol, Stephen J. , Orr, Robert, Steen, Hanno , Sellers, Zachary M.

Mayo Clinic

Pancreas | October 16, 2018 | Volume: 47 | Issue: 10 | Pages: 1213-1221

10.1097/mpa.0000000000001171 | PMID 30325860 Get It

Abstract High-quality and well-annotated biorepositories are needed to better understand the pathophysiology and biologic mechanisms of chronic pancreatitis (CP) and its consequences. We report a methodology for the development of a robust standard operating procedure (SOP) for a biorepository based on the experience of the clinical centers within the consortium to study Chronic Pancreatitis, Diabetes and Pancreas Cancer Clinical Centers (CPDPC), supported by the National Cancer Institute and the National Institute for Diabetes and Digestive and Kidney Diseases as a unique multidisciplinary model to study CP, diabetes, and pancreatic cancer in both children and adults. Standard operating procedures from the CPDPC centers were evaluated and consolidated. The literature was reviewed for standard biorepository operating procedures that facilitated downstream molecular analysis. The existing literature on biobanking practices was harmonized with the SOPs from the clinical centers to produce a biorepository for pancreatic research. This article reports the methods and basic principles behind the creation of SOPs to develop a biorepository for the CPDPC. These will serve as a guide for investigators developing biorepositories in pancreas research. Rigorous and meticulous adherence to standardized biospecimen collection will facilitate investigations to better understand the pathophysiology and biologic mechanisms of CP, diabetes, and pancreatic cancer.
PROspective Evaluation of Chronic Pancreatitis for EpidEmiologic and Translational StuDies
Yadav, Dhiraj , Park, Walter G. , Fogel, Evan L. , Li, Liang , Chari, Suresh T. , Feng, Ziding , Fisher, William E., Forsmark, Christopher E., Habtezion, Aida , Hart, Phil A. , Hughes, Steven J. , Othman, Mohamed O. , Rinaudo, Jo Ann, Serrano, José , Srivastava, Sudhir , Topazian, Mark , Conwell, Darwin L. , Serrano, Jose , Jeon, Christie Y. , Pandol, Stephen J. , Tirkes, Temel , Van Den Eeden, Stephen K , Whitcomb, David C. , Chari, Suresh T

Mayo Clinic

Pancreas | October 16, 2018 | Volume: 47 | Issue: 10 | Pages: 1229-1238

10.1097/mpa.0000000000001170 | PMID 30325862 Get It

Abstract Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies (PROCEED) is the first prospective, observational cohort study of chronic pancreatitis (CP) in the United States. The primary goals of PROCEED are to define disease progression, test the predictive capability of candidate biomarkers, and develop a platform to conduct translational and mechanistic studies in CP. Using objective and consensus-driven criteria, PROCEED will enroll adults at different stages of CP—controls, suspected CP, and definite CP. In addition to collecting detailed information using structured case report forms and protocol-mandated evaluations at baseline and during follow-up, PROCEED will establish a linked biorepository of blood, urine, saliva, stool, pancreatic fluid, and pancreatic tissue. Enrollment for PROCEED began in June 2017. As of July 1, 2018, nine clinical centers of the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer are enrolling, and 350 subjects have completed baseline evaluation. In conclusion, PROCEED will provide the most accurate and reliable estimates to date on progression of CP. The established cohort and biorepository will facilitate numerous analyses, leading to new strategies for diagnosis, methods to monitor disease progression, and treatment of CP.
Intercepting Pancreatic Cancer
Lippman, Scott M. , Constantinou, Pamela E., Petersen, Gloria M. , Goggins, Michael , Jacks, Tyler , Syngal, Sapna , Maitra, Anirban

Mayo Clinic

Pancreas | October 16, 2018 | Volume: 47 | Issue: 10 | Pages: 1175-1176

10.1097/mpa.0000000000001165 | PMID 30325853 Get It

Accelerated emergence from a nontraumatic minimally conscious state with levodopa/carbidopa
Bancalari, Ernesto , Machiavello, Francisco, Desmaison, Alejandro, Rabinstein, Alejandro A.

Mayo Clinic

Neurology Clinical Practice | October 16, 2018 | Volume: 8 | Issue: 6 | Pages: 541-542

10.1212/cpj.0000000000000508 | PMID 30588385 Get It

Work-Related Musculoskeletal Discomfort and Injury in Microsurgeons
Howarth, Ashley L. , Mahabir, Raman C. , Lemaine, Valérie, Evans, Gregory R. D. , Noland, Shelley S. , Hallbeck, Susan, Hallbeck, M. Susan

Mayo Clinic

Journal of Reconstructive Microsurgery | October 16, 2018 | Volume: 35 | Issue: 05 | Pages: 322-328

10.1055/s-0038-1675177 | PMID 30326524 Get It

Background Long surgical procedures with loupe magnification and microscopes may put microsurgeons at an increased risk of musculoskeletal discomfort. Identifying the prevalence and impact of work-related musculoskeletal discomfort may guide preventive strategies to prolong well-being, job satisfaction, and career duration. Methods An online 29-question survey was designed to evaluate work-related musculoskeletal discomfort. The survey was created and distributed electronically through a private survey research center and was sent to the members of the American Society for Reconstructive Microsurgery. Results There were 117 respondents (16.7% response rate): 80% were men; 69% were aged 31 to 50 years; and 68% were in academic practice. On a scale of 0 to 10 (0, no pain and 10, worst pain), the median for work-related musculoskeletal discomfort for surgery without loupes or microscope was 2; with loupes, 4; and with a microscope, 5. Pain was most common in the neck. Half of the surgeons reported pain within 4 hours of surgery, and 57% feared that pain would influence future surgical performance. Surgeon discomfort affected posture (72%), stamina (36%), sleep (29%), relationships (25%), concentration (22%), and surgical speed (19%). Tremor caused by the discomfort occurred in 8%. Medical treatment for discomfort was sought by 29%. Time off work for treatment occurred for 8%. Conclusion Work-related musculoskeletal discomfort can affect many aspects of a microsurgeon's life and has the potential to limit a surgeon's ability to operate. Therefore, more emphasis is needed in the surgical community on the important issues of occupational health and surgical ergonomics for microsurgeons.
Diagnostic accuracy of the McGill thyroid nodule score in paediatric patients
Creo, Ana L. , Alahdab, Fares , Nofal, Alaa Al , Thomas, Kristen B. , Kolbe, Amy B. , Pittock, Siobhán T. , Creo, Ana , Al Nofal, Alaa , Thomas, Kristen, Kolbe, Amy , Pittock, Siobhan , Alahdab, Fares

Mayo Clinic

Clinical Endocrinology | October 16, 2018 | Volume: 90 | Issue: 1 | Pages: 200-207

10.1111/cen.13878 | PMID 30326152 Get It

AbstractIntroductionThyroid cancer is the most common paediatric endocrine cancer; accurate diagnosis and prompt management of paediatric thyroid nodules is critical. The McGill Thyroid Nodule Score (MTNS), based upon clinical, ultrasound (US) and cytology criteria, has recently been modified and studied in a pilot paediatric group with good results. We aim to describe the diagnostic accuracy of the paediatric modified MTNS (PMTNS) in a large paediatric cohort.MethodsWe utilized an established retrospective cohort between 1996 and 2015 of 99 patients ≤21 years old with 131 thyroid nodules. Two experienced paediatric radiologists, blinded to pathology and radiology reports, reviewed US features. We abstracted cytology, histology and laboratory results, assigning each nodule a PMTNS. PMTNS performance was compared to FNA and histology.ResultsApproximately 33% of nodules were malignant. The cohort was predominantly adolescent (mean age 15.4 ± 3.8 years). The average PMTNS for malignant and benign nodules, based on final histology, was 12.7 ± 4.3 and 1.7 ± 2.9, respectively. A PMTNS ≥8 resulted in a 93.2% sensitivity and 93.1% specificity for detecting malignancy, while a PMTNS ≥9 resulted in a 90.9% sensitivity and 96.6% specificity. However, Bethesda cytology category ≥4 independently had a 97.7% sensitivity and 94.0% specificity for detecting malignancy. The PMTNS had diminishing diagnostic accuracy in younger children compared with older children.ConclusionPaediatric modified McGill Thyroid Nodule Score predicts malignancy, perhaps due to the score's emphasis on cytology results; however, the score is less accurate in younger patients. While cytology results remain reliable, further work is needed to develop a non‐invasive scoring system to predict malignancy in children.
An organizational laser safety program at Mayo Clinic in Arizona
Wesselius, Lewis , Frederiksen, Sharli, Walton, H., Pasquariello, Tom, Didehban, Roshanak, Fleeger, Rick, Friedman, Lisa, Frederiksen, Sharli, Walton, Heidi, Harikumar, Kaleeckal G.

Mayo Clinic

ILSC 2007: Proceedings of the International Laser Safety Conference | October 16, 2018 | Volume: No volume available | Issue: No issue available | Pages: 218-220

10.2351/1.5056636 Get It

In January 2006, a regulatory review of the Mayo Clinic in Arizona Laser Safety Program received high praise from the Arizona Radiation Regulatory Agency (ARRA). This feedback was especially encouraging as the Laser Safety Program had undergone a transformation in structure as well as launching an intensive marketing campaign during the previous 18 months. This presentation outlines the re-organization and describes the tools utilized by the team to accomplish the program objectives.
The laser time out; Ensuring safe operation of lasers in the operating room suite
Ryan, Marthalane M., McCormick, Shari, Schaitberger, Sharli, Baldea, Barb, Hinni, Michael L.

Mayo Clinic

ILSC 2013: Proceedings of the International Laser Safety Conference | October 16, 2018 | Volume: No volume available | Issue: No issue available | Pages: 213-216

10.2351/1.5056793 Get It

Airway fires in the surgical suite are catastrophic and deadly. When there is a combination of an endotracheal (ET) tube filled with oxygen and an ignition source such as a laser, the standard ET tube acts like a blowtorch in the patient’s trachea. These tubes can be ignited at oxygen levels as low as 26% [1]. Laser safety programs should incorporate measures to isolate the triad that is present in all Operating Room (OR) fires: a source of oxygen, fuel, and ignition. Although safety hazards are inherent when lasers are used in the OR, they can be significantly reduced, if not eliminated, if proper procedures are implemented and adhered to whenever a laser is utilized in the OR. This article reviews the safety hazards and the implementation of a “Laser Time Out” to allow for the safe use of lasers in the Operating Room.
Laser dyes and solvents
Frederiksen, Sharli

Mayo Clinic

ILSC 2011: Proceedings of the International Laser Safety Conference | October 16, 2018 | Volume: No volume available | Issue: No issue available | Pages: 124-126

10.2351/1.5056734 Get It

Organic dye solutions can serve as the lasing medium in some laser systems. A few examples of laser dyes include coumarin, fluorescein, malachite green, rhodamine, and stilbene. Most laser dyes, or the solvents in which they are dissolved, are toxic; some are carcinogenic or mutagenic. A few examples of some common laser dye solvents include water, glycol, alcohols, benzenes, hexane, toluene, cyclohexane, and dimethylformamide. As the laser is used, the dye solutions degrade and eventually have to be replaced. It is probable that the waste laser dye solution will need to be handled as a hazardous chemical. Proper characterization is needed prior to handling to determine the specific hazards and control measures to prevent exposure to the engineer or the environment. Hazardous waste regulations vary by location, but there is similarity in that all restrict toxic materials from polluting the environment.
Follicular Dendritic Cell Sarcoma With NF2 Mutation
Karrs, Jeremiah , Gohlke, Amanda Lynn, Oliveira, André M. , Richard, Hope , Pavlick, Dean C. , Smith, Steven C. , Poklepovic, Andrew

Mayo Clinic

AJSP: Reviews and Reports | October 16, 2018 | Volume: 23 | Issue: 6 | Pages: 251-254

10.1097/pcr.0000000000000277 Get It

Abstract Follicular dendritic cell sarcoma (FDCS) is recognized as a diagnostically challenging neoplasm requiring rigorous exclusion of more common entities and high index of suspicion for diagnosis. Here, we report an aggressive case of FDCS arising in the mediastinum, which due to sampling limitations and the inherent difficulty of diagnosis required extensive workup with multiple samples prior to definitive classification. The patient was a 35-year-old woman who presented with progressive dyspnea and mediastinal mass on imaging studies. The initial sampling of the lesion had histologic features raising consideration of FDCS, but was too limited to allow definitive diagnosis, while progressing rapidly enough to require administration of chemotherapy even prior to classification. Repeat samples obtained via fine-needle aspiration and bronchoscopy enabled the diagnosis of FDCS, and high-throughput sequencing revealed apparently pathogenic NF2 mutations previously not reported in this disease. Unfortunately, the patient died of widely metastatic disease, which we comprehensively documented at autopsy. Together, these observations provide previously unreported insights into the end stage of this disease and experience relevant to its prospective recognition and workup.